SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings is trending due to high short interest and a strategic shift towards integrated energy solutions, sparking discussions of a potential short squeeze. The community is debating the stock's volatility, with some urging others to hold strong while others are wary of a potential pump and dump. Bullish investors are comparing it to previous squeeze events.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia's performance post-earnings is sparking mixed reactions, with some questioning if the AI hype is sustainable as the stock struggles to hold gains despite positive results. The community is debating potential accounting issues and the concentration of revenue among a few key customers, while others see this as a temporary dip before a larger rally driven by long-term AI growth. Concerns about valuation, market manipulation, and broader economic headwinds are also fueling the discussion.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending due to rising memory chip prices driven by AI data center demand, with some analysts predicting substantial future growth and a new price target. Community discussions reflect bullish sentiment, but also caution about potential pullbacks after a significant year-to-date increase. Some traders point to technical indicators suggesting it may be overbought in the short-term.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

MCRB is trending as the community speculates about a potential buyout, with many pointing to Nestle as a likely suitor given past collaborations and recent corporate restructuring. Discussions revolve around the timing of a deal before the end of the year, potential offer prices, and the impact on shareholders. Some traders are expressing skepticism, citing possible pump-and-dump schemes or an upcoming offering.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending due to positive community sentiment fueled by strong earnings and a potential shift to a tech-forward image with a possible move to the Nasdaq. Discussions also revolve around the impact of consumer spending habits, SNAP benefits, and competition with other retailers. The stock is experiencing increased interest and mentions as a key player in the retail sector.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending downwards, sparking debates about whether it's a temporary dip or the start of a longer bear market, as community members analyze support levels and potential bottom prices. Mixed opinions are fueled by discussions of market manipulation, external factors like potential strategic reserves, and comparisons to the performance of traditional markets. Some traders express concern over heavy liquidations, while others remain optimistic about long-term prospects and institutional adoption.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing significant volatility, driven by reactions to economic data and sector-specific news like NVDA's earnings. Community chatter highlights a struggle between bulls and bears, with many discussing potential bull traps and the impact of AI on the market. Traders are closely watching key support and resistance levels amid uncertainty about future rate cuts.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is experiencing significant volatility, with community discussions focused on potential downside risks and the correlation with Bitcoin's price movements. Bearish sentiment seems to be growing as some traders discuss shorting opportunities and question the company's long-term prospects given its leveraged position in Bitcoin. Others remain bullish, citing oversold conditions and potential for a rebound.

Bitmine Immersion Technologies, Inc. is a blockchain technology company, which engages in industrial scale digital asset mining, equipment sales, and hosting operations. It operates through the Cryptocurrency Mining Industry segment. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is trending amid volatile crypto markets and a recent downturn, leading to heightened community discussion around unrealized losses and potential bottom prices. Investors are closely watching for a potential announcement regarding staking rewards to support the stock's price, while also debating the influence of analysts like Tom Lee and market factors on BMNR's performance in relation to Ethereum.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending as investors react to news of billionaire investors loading up on the stock and a recent court ruling impacting driver employment status in New Zealand. The community is also buzzing about potential mergers and the possibility of autonomous vehicle developments with partners like Tesla and Waymo. Despite positive free cash flow, some traders are wary of technical indicators and hedging strategies.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Matt Kinsella said that computing is not the only product coming from quantum technologies.</li><li>There's a&nbsp;wide range of other products, including quantum sensors, quantum clocks, RF antennas, gravimeters, and&nbsp;different types of inertial sensing equipment.</li><li>Citing McKinsey’s research, the executive said Infleqtion’s total addressable market (TAM) is about $160 billion.</li></ul>Quantum computing company Infleqtion is set to go public via a Special Purpose Acquisition Company (SPAC) deal with Churchill Capital Corp. (CCCX), a blank-check company founded by ex-Citi executive Michael Klein. The ongoing government shutdown may have pushed back the going-public timeline slightly.&nbsp;Still, it hasn’t dampened Infleqtion CEO Matt Kinsella's optimism&nbsp;about&nbsp;what the future holds out for the company.Since the SPAC deal was announced, <a href="https://stocktwits.com/symbol/CCCX">Churchill Capital stock</a> has gained about 60%.Stockwits sat down with Kinsella, a former venture capitalist and a breakthrough technology evangelist, for a freewheeling chat about Inflqeqtion and its way forward:Here are excerpts from the interview:<h2 class="st-heading-2">Quantum Tech Is Much More Than Computing</h2>Kinsella attributed the skepticism toward the quantum computing industry to&nbsp;the pushed-out timelines. “For the last 20 years, it's always kind of been, oh, in five years we'll have quantum computing. It's always been this kind of rolling five years, and when you get there, it's five years from now we'll have it, and then five years from now you'll have it,” he said.The skepticism, according to the executive, stems from a bucket of misconceptions — that computing is the only product&nbsp;emerging from&nbsp;quantum technologies. “There's a whole umbrella of other types of products, such as quantum sensors, where quantum is already developing products that are truly orders of magnitude better than classical standards.” He also mentioned products such as quantum clocks, RF antennas, gravimeters, and other types of inertial sensing equipment.<h2 class="st-heading-2">Quantum Space In An Excited State</h2>Quantum computing stocks began the year on a slow note as they digested the torrid gains made in 2024, most of which occurred late in the year. These stocks also moved in tandem with the broader market when it declined sharply in early April, following President Donald Trump's announcement of punitive tariffs.&nbsp;Rumors that the Trump administration was eyeing stakes in quantum companies provided a solid boost to these stocks in October. D-Wave Quantum is among the best-performing publicly listed quantum companies this year,&nbsp;with gains exceeding 175%.<img src="https://news.stocktwits-cdn.com/QC_Stocks_Price_Gains_png_8e6c1e3da2.webp" alt="QC Stocks Price Gains.png">Source: KoyfinCitron Research touted in early October that Infleqtion is a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-spac-churchill-capital-s-stock-is-jumping-premarket-today/ch6EfqhR3Ln">far better quantum play&nbsp;</a>than Rigetti.Big Tech companies have also made significant inroads in quantum computing, with Alphabet announcing its Willow quantum chip late last year. Last month, it unveiled a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/elon-musk-tips-hat-to-sundar-pichai-for-google-s-latest-quantum-leap/cLG49mqR3Ag">breakthrough quantum algorithm,</a> dubbed “Quantum Echoes,”&nbsp;which CEO Sundar Pichai&nbsp;claims is 13,000 times faster than the best classical algorithm on one of the world's fastest supercomputers.&nbsp;That earned adulation even from Tesla CEO Elon Musk, who replied, “Looks like quantum computing is becoming relevant.”&nbsp;On Wednesday, IBM unveiled IBM Quantum Nighthawk, its most advanced quantum processor yet. As the industry makes slow and steady progress toward large-scale commercial adoption, Infleqtion finds itself in the sweet spot, positioning itself as a provider of a broad array of quantum products.<h2 class="st-heading-2">The Qubit Conundrum</h2>Kinsella said another misconception is a lack of understanding of the concept of logical qubits.&nbsp;A qubit&nbsp;is the basic unit of information in quantum computing, analogous to a bit in classical computing.He said Infleqtion holds the record for commercial qubits at 1600. “These are physical qubits, but what really matters in quantum computing are logical qubits. And logical qubits are error-corrected physical qubits.”“And it's generally thought that at 100 logical qubits, we will start to be able to do things with quantum computers that classical computers can't do.”Kinsella conceded that in terms of quantum computing, “we are not yet there.” While companies have different roadmaps for their logical qubits, Infleqtion plans to have 100 logical qubits by 2028. “So I think that's a reasonable line in the sand to say we'll start to do things that are commercially useful with quantum computers.”<h2 class="st-heading-2">Trump’s Quantum Thrust</h2>To a question about the Trump administration’s rumored interest in taking stakes in quantum computing companies, just as it invested in rare earth companies, Kinsella said such a move is possible. “I think it's the mentality of this administration to have taxpayers benefit from work that the government does with various deep tech companies.”Kinsella said the U.S. government is Infleqtion’s biggest customer and the company is constantly in talks with the government. “The topic of equity is brought up from time to time, and so I think, you know, we will continue to do a lot of business with the U.S. government, and those conversations will play out as they play out.”<h2 class="st-heading-2">China Competition</h2>It’s a race with China, just like it is in other areas. Kinsella said China is investing significantly more dollars in quantum than the U.S. has historically, but the U.S., along with its allies, invests more than China does. “But importantly, I think the U.S. is doing what it does often, and that's relying on its private capital markets to fund the innovation.”<h2 class="st-heading-2">Biggest Customer</h2>Kinsella said government accounts for more than 50% of Infleqtion’s revenue, with the Department of Defense (DoD) and government-run energy grids included in this category. The&nbsp;company also sells its clocks to non-governmental customers and academic institutions.Citing McKinsey’s research, the executive stated that Infleqtion’s total addressable market (TAM) is approximately $160 billion, comprising $30 billion in quantum sensing revenue and $130 billion in quantum computing revenue.&nbsp;<h2 class="st-heading-2">Consolidation In the Offing?</h2>While hinting that quantum computing is not a zero-sum game, Kinsella sees some degree of consolidation. “I think you'll probably end up with a handful of very large, very important quantum companies over the course of the next five to 10 years.”“One of the reasons why&nbsp;Infleqtion is going public is because I think we will be one of those consolidators, and we'll be one of those important companies. I think we have a head start now and an advantage, and we want to compound that advantage going forward.”<h2 class="st-heading-2">Government Shutdown Throws A Wrench</h2>Kinsella said Infleqtion was shooting for the end-of-the-year listing timeframe. “I hadn't really factored in the government shutdown into my calculations, and so I think it'll probably be in Q1, assuming the government gets reopened. Is it January or March? I don't know at this point.” The executive noted that the company has filed the S4 report confidentially with the SEC.<h2 class="st-heading-2">Message For Retail Investors</h2>“I personally believe quantum is going to be a very important technological shift for humanity over the course of the next decade. And I think it's great that the retail investing community is going to have more options to be able to participate in that over time,”&nbsp;Kinsella said, urging retail investors to do their due diligence. “But I think it's great that there will be the opportunity to invest in, you know, now another quantum company like Infleqtion.”“If you want to have exposure to the broad spectrum of opportunities that quantum can provide across both sensing and computing, Infleqtion is a very good way to represent that broader quantum bet.”Infleqtion will be the only publicly traded neutral-atom quantum, he said.&nbsp;That means it’s a company&nbsp;that develops quantum computers using neutral atoms, which&nbsp;lack an electrical charge. These companies use lasers to trap and manipulate these neutral atoms, arranging them into precise configurations to act as qubits for complex calculations.Kinsella thinks “neutral atoms are going to be the ones that win in quantum computing and therefore, we would be the way to express that.”For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/intel-hit-by-ai-brain-drain-as-top-execs-depart-for-rivals/cLPdQ7DRE2w">&nbsp;Intel Hit By AI Brain Drain As Top Execs Depart For Rivals: Sachin Katti Joins OpenAI After Saurabh Kulkarni's Jump To AMD</a>

 Citron Research touted in early October that Infleqtion is a far better quantum play than Rigetti.

EXCLUSIVE: Quantum Stocks Are Still Hot — And Infleqtion's CEO Sees Industry Consolidation, $160B Opportunity As It Heads For SPAC Listing

Quantum computing company Infleqtion is set to go public via a Special Purpose Acquisition Company (SPAC) deal with Churchill Capital Corp. 

Quantum Stocks Are Still Hot — And Infleqtion's CEO Sees Industry Consolidation, $160B Opportunity As It Heads For SPAC Listing

Equity

Matt Kinsella says quantum technology will be a major technological shift for humanity over the next decade.


<ul class="summary-bullets"><li>CEO Kevin McAleenan said, with the Ask Sage deal, BigBear is creating a secure, integrated AI platform that connects software, data, and mission services in one place.</li><li>The deal is expected to close in either the fourth quarter or the first quarter of next year.</li><li>Despite the ongoing government shutdown, the company reaffirmed its 2025 revenue guidance.</li></ul>Big Bear.ai Holdings, Inc. (BBAI) stock jumped over 12% in Monday’s extended session after the company reported a third-quarter beat and announced an M&amp;A deal, buoying retail sentiment.<a href="https://stocktwits.com/symbol/BBAI">BigBear stock</a> has been on a volatile ride this year en route to its 28% year-to-date gains.&nbsp;<h2 class="st-heading-2">BigBear’s Doubled Down AI Bet</h2>The McLean, Virginia-based artificial intelligence (AI)-powered decision intelligence solutions company said it has signed an agreement to buy Ask Sage for $250 million. Ask Sage is a generative AI (GenAI) platform designed for the secure distribution of AI models and agentic AI capabilities, primarily for defense and national security agencies and other highly regulated sectors.Big Bear noted that Sage already supports more than 100,000 users on 16,000 government teams and across hundreds of commercial companies. Ask Sage is expected to deliver annual recurring revenue (ARR) of approximately $25 million in 2025, nearly six times the amount it recorded in 2024.&nbsp;CEO Kevin McAleenan said, “By integrating Ask Sage with BigBear.ai, we are creating what the market has been asking for: a secure, integrated AI platform that connects software, data, and mission services in one place.” The deal is expected to close in either the fourth quarter of 2025 or the first quarter of 2026.<h2 class="st-heading-2">BigBear’s Q3 Earnings Snapshot</h2>The net loss per share for the fiscal year 2025 fourth quarter narrowed to $0.03 from $0.06 a year ago, and revenue fell 20% year over year (YoY) to $33.1 million. The results, however, exceeded the Fiscal.ai-compiled consensus estimates for a loss of $0.07 and revenue of $31.82 million.The company blamed the YoY revenue drop on lower volume in certain Army programs, and said the narrower net loss is due to non-cash changes in the fair value of the convertible 2029 notes and warrants.&nbsp;Gross margin contracted 350 basis points YoY due to the absence of some high-margin programs that benefited the year-ago quarter.BigBear ended the quarter with a backlog of $376 million.<h2 class="st-heading-2">BigBear’s Outlook</h2>Despite the ongoing government shutdown, the company reaffirmed its 2025 revenue guidance of $125 million to $140 million, which aligns with the consensus estimate of $133.53 million.<h2 class="st-heading-2">What BigBear Retail Feels About Stock After Q3 Print</h2>On Stocktwits, retail sentiment toward the stock shifted to ‘bullish’ as of early Tuesday, from ‘bearish’ a day ago. The 24-hour message volume leading up to late&nbsp; Monday surged up by about 1,500%.<figure class="image"><img style="aspect-ratio:677/58;" src="https://news.stocktwits-cdn.com/Screenshot_2025_11_11_at_12_27_52_AM_png_f6bac86ee7.webp" alt="Screenshot 2025-11-11 at 12.27.52 AM.png" width="677" height="58"><figcaption>BBAI sentiment and message volume as of 2:25 a.m. ET, Nov. 11 | source: Stocktwits</figcaption></figure>A bullish watcher said there is a good chance the stock will open above $7 on Tuesday.<stembedurl>https://stocktwits.com/MyEfund/message/635695260</stembedurl>Another user expressed comfort in&nbsp;holding the stock. “I don’t feel as bad holding this stock anymore after today’s earnings call.”<stembedurl>https://stocktwits.com/DARK_SCROOGIE/message/635690861</stembedurl>The average analysts' price target for BigBear stock is $5.83, according to Koyfin, implying roughly 2% upside from Monday's closing price.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/intel-hit-by-ai-brain-drain-as-top-execs-depart-for-rivals/cLPdQ7DRE2w">Intel Hit By AI Brain Drain As Top Execs Depart For Rivals: Sachin Katti Joins OpenAI After Saurabh Kulkarni's Jump To AMD</a>

The logo of BigBear.ai Holdings, Inc. displayed on a smartphone screen, with the company's latest stock market chart visible in the background on April 26, 2025, in Chongqing, China. (Photo illustration credit: Cheng Xin/Getty Images)

BigBear Stock Surges Over 12% After-Hours On $250M Ask Sage Deal, Q3 Beat — Retail Impressed With Results

BigBear announced a strategic acquisition of a GenAI platform, which is growing revenue at a scorching pace.

BigBear Stock Surges Over 12% After-Hours On $250M Ask Sage Deal, Q3 Beat

<ul class="summary-bullets"><li>According to Fiscal.ai-compiled consensus, BigBear is expected to report a loss per share of $0.07 and revenue of $31.82 million.</li><li>During the quarter, the company announced several deals, including one that aims to deploy advanced AI and orchestration technologies in support of the U.S. Navy.</li><li>BigBear stock is up about 17.7% YTD.</li></ul>Big Bear.ai Holdings, Inc. (BBAI) stock rallied nearly 4% in premarket trade ahead of the company’s quarterly earnings report, due after the market closes on Monday. The artificial intelligence (AI)-powered decision intelligence solutions firm has attracted attention from retail traders, even as analysts forecast a wider loss and lower revenue compared to last year.For the year-to-date period,&nbsp;<a href="https://stocktwits.com/symbol/BBAI">BigBear stock</a> has gained about 17.7%, underperforming the broader market and the tech sector.<h2 class="st-heading-2">Retail Excited About BigBear’s Q3</h2>When retail users of the Stocktwits platform were asked which earnings report they were most excited for the week of Nov.10, a majority picked BigBear, reflecting interest in the stock. An ongoing poll that has received responses from 11,200 users so far has shown that 30% are excited about BigBear’s earnings. AST SpaceMobile (ASTS), Nebius N.V. (NBIS) and Rocket Lab (RKLB) were mentioned by 25%, 23% and 22% of the respondents, respectively.<a href="https://stocktwits.com/StocktwitsPolls/message/635353734"><img src="https://news.stocktwits-cdn.com/Screenshot_2025_11_10_at_4_37_04_AM_png_a62853f334.webp" alt="Screenshot 2025-11-10 at 4.37.04 AM.png"></a>A Stocktwits user hoped the stock would gain enough momentum to hit double digits before Christmas, based on the view that BigBear's earnings report would not be too bad. Another user stated that the stock is poised to take off and will continue rallying until the end of the year. They set their sights on $12.<stembedurl>https://stocktwits.com/Paul243/message/635557229</stembedurl><stembedurl>https://stocktwits.com/Ohad12/message/635559688</stembedurl>A third user said he would continue to stack the stock.<stembedurl>https://stocktwits.com/marzo34/message/635554283</stembedurl><h2 class="st-heading-2">What Analysts Expect From BigBear’s Q3 Print</h2>According to Fiscal.ai-compiled consensus, BigBear is expected to report a loss per share of $0.07 and revenue of $31.82 million. This compares to the year-ago’s loss per share of $0.05 and revenue of $41.51 million.During the quarter, the company announced several deals, including one that aims to deploy advanced AI and orchestration technologies in support of the U.S. Naval Forces Southern Command. The company also announced a strategic partnership with Tsecond to deliver AI-enabled edge infrastructure for mission-critical operations.The average analysts’ price target for BigBear stock is $5.83, according to Koyfin, implying roughly 2.70% potential upside.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-rumble-stock-is-soaring-nearly-16-in-premarket/cLPcX3hREcH">Why Rumble Stock Is Soaring Nearly 16% In Premarket</a>

In this photo illustration, a person holds a smartphone displaying the logo of BigBear.ai Holdings, Inc. (NYSE: BBAI), on August 8, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

BigBear Retail’s Top Earnings Pick Of The Week Ahead: Stock Gains Nearly 4% Premarket Ahead Of Q3 

BigBear retail is buzzing about the stock taking off and rallying through the year-end.

<ul class="summary-bullets"><li>Strive, following its merger with Asset Entities in mid-September, announced plans to become a Bitcoin holding company.</li><li>Bitcoin topped the $116K earlier in the Asian session, before giving back some of the gains.</li><li>The optimism toward cryptocurrencies stemmed from a raft of catalysts, including the brightening prospects of a U.S.-China deal.</li></ul>Strive Asset Management, LLC (ASST) stock climbed sharply in Monday’s early premarket session, signaling that it may rise for a third consecutive session.On Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/ASST">Strive stock</a> remained ‘extremely bullish’ as of early Monday, and the message volume jumped to ‘extremely high’ levels.<h2 class="st-heading-2">Strive’s Bitcoin-Inspired Rally?</h2>Nasdaq-listed Asset Entities, a marketing company, closed its merger with asset management company Strive in mid-September, retaining the Strive name and ‘ASST’ ticker. The company, co-founded by Vivek Ramaswami, announced plans to become a Bitcoin (BTC) holding and marketing company.ASST’s premarket gains on Monday could be traced to strong gains in Bitcoin (BTC), which topped the $116K earlier in the Asian session,&nbsp;before giving back some of the gains. The optimism toward crypto stemmed from a raft of catalysts, including the brightening prospects of a U.S.-China deal following productive high-level talks between the two countries in Malaysia over the weekend.Hopes of a rate cut from the Federal Reserve’s rate-setting committee, when it meets for a two-day meeting that kicks off on Tuesday, also lent support to cryptocurrencies.<h2 class="st-heading-2">What Retail’s Feeling About Strive Stock</h2>Retail’s interest in Strive’s stock has been on the rise, with the one-year follower count rising 675% and the message volume over the past seven days leading up to late Sunday was up over 900%.A bullish watcher lauded the company for the bold move to merge and become the first public Bitcoin treasury company, backed by a massive $750 million funding plan. “Big vision, big potential!” they said.<stembedurl>https://stocktwits.com/StockGuru95/message/633790891</stembedurl>Another user expected algorithmic buying on Monday, just like last Friday, when it ripped before remaining stuck for a long time.<stembedurl>https://stocktwits.com/Ammylovlov/message/633790840</stembedurl>Since its mid-September listing, the stock has lost about 82%. In premarket, the stock climbed over 26% on top of Friday’s 27%+ rally.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-avidity-biosciences-stock-is-jumping-over-43-in-premarket-today/cLG0dICR3Ma">Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today</a>

Why Strive Stock Is Ripping Higher In Premarket Today

Strive Asset Management, LLC (ASST) stock climbed sharply in Monday’s early premarket session, signaling that it may rise for a third consecutive session.

Why Strive (ASST) Stock Is Ripping Higher In Premarket Today

<ul class="summary-bullets"><li>Novartis has agreed to buy Avidity Biosciences in a deal valued at $72 per share.</li><li>The deal is expected to close in the first half of 2026.</li><li>Retail sentiment toward Avidity Biosciences stock flipped to ‘extremely bullish’ by early Monday from ‘bearish’ a day ago.</li></ul>Avidity Biosciences, Inc. (RNA) shares&nbsp;soared over 43% in Monday’s early premarket session after the mid-cap biopharma focusing on developing RNA therapeutics called antibody oligonucleotide conjugates (AOC), announced a deal to be bought by Swiss pharma giant Novartis (NVS).<a href="https://stocktwits.com/symbol/RNA">Avidity Biosciences</a> stock has gained more than 60% this year.<h2 class="st-heading-2">The Novartis Deal Terms</h2>In a statement released on Sunday, Novartis said it would acquire San Diego-based Avidity Biosciences following the separation of the latter’s early-stage precision cardiology programs. The deal, approved by the boards of both companies, is valued at $72 per share in cash. This represented a 46% premium over RNA stock’s closing price of $49.15 on Friday.The total transaction value is $12 billion on a fully diluted basis. Avidity Biosciences currently boasts a market capitalization of $7.17 billion.Vas Narasimhan, CEO of Novartis, said, “Avidity’s pioneering AOC platform for RNA therapeutics ​and its late-stage assets bolster our commitment to delivering innovative, targeted, and potentially first-in-class medicines to treat devastating, progressive neuromuscular diseases.”Before the merger's closing, Avidity will transfer its early-stage precision cardiology programs and collaborations to SpinCo, a wholly owned subsidiary of Avidity. Holders of Avidity common stock will receive a distribution of one share of SpinCo for every ten shares of Avidity they hold and/or a pro rata cash distribution of the proceeds received by Avidity before the closing if certain SpinCo assets are, or SpinCo itself is, sold to a third party.The deal is expected to close in the first half of 2026, subject to the completion of a spin-off or the sale of SpinCo and other customary closing conditions, including the receipt of regulatory approvals and the approval of Avidity stockholders.Novartis said the proposed acquisition raises the expected 2024-2029 sales growth from 5% to 6% on a compounded annual growth rate (CAGR) basis, representing a significant opportunity to deliver substantial shareholder returns over time.<h2 class="st-heading-2">What Retail’s Saying About The Buyout Deal</h2>Retail sentiment toward Avidity Biosciences stock flipped to ‘extremely bullish’ by early Monday from ‘bearish’ a day ago. The message volume on the stream also improved to ‘extremely high.’&nbsp; Retail chatter spiked 6,100% over the 24 hours leading up to late Sunday.<figure class="image"><img style="aspect-ratio:620/56;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_27_at_6_02_00_AM_png_9d47ea362a.webp" alt="Screenshot 2025-10-27 at 6.02.00 AM.png" width="620" height="56"><figcaption>RNA sentiment and message volume as of 6 a.m. ET, Oct. 27 | source: Stocktwits</figcaption></figure>A bullish user noted that RNA traded at $5 two years ago and congratulated the believers.<stembedurl>https://stocktwits.com/Cutlass/message/633766787</stembedurl>Another user said they would cash out on Monday.<stembedurl>https://stocktwits.com/ure300/message/633760283</stembedurl>Earlier this month, Avidity Biosciences said it has completed a positive pre-Biologic License Application (BLA) meeting with the FDA regarding its delpacibart zotadirsen, an investigational drug being evaluated as a potential treatment for people living with Duchenne muscular dystrophy (DMD) who have gene mutations amenable to exon 44 skipping.&nbsp;The timing for the BLA submission was pushed back to the first quarter of 2026 from the previous guidance of year-end 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/palantir-rises-premarket-today-as-stock-closes-in-on-200-psychological-threshold/cLG0TBNR3Md">Palantir Rises Premarket Today As Stock Closes In On $200 Psychological Threshold: What’s Driving The Gains?</a>

Researcher performing microbiology separator for PCR diagnosis test in pathology laboratory. 

Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today

Novartis has agreed to buy Avidity Biosciences in a deal valued at $72 per share.

Why Avidity Biosciences Stock Is Jumping Over 40% In Premarket Today

&nbsp;<ul class="summary-bullets"><li>In an amended&nbsp;regulatory filing, AiRWA confirmed a stake built by director Michael Anthony Belfiore.</li><li>According to the filing, he now holds a 22.1% stake in AiRWA.</li><li>Retail expects “FOMO” fear will kick in once the stock reaches $0.50.</li></ul>Nano-cap AiRWA, Inc.’s (YYAI) stock fell for two consecutive sessions this week, but rebounded by nearly 32% in Tuesday’s after-hours session, accompanied by substantial volume,&nbsp;following a filing by the company confirming an insider’s stake build.<a href="https://stocktwits.com/symbol/YYAI">AiRWA stock</a>, which has traded in a 52-week range of $0.0670 to $6.33, has elicited a strong bullish reaction from retail traders.<h2 class="st-heading-2">Insider Accumulates AiRWA Stock</h2>In an amended Schedule 13D filing with the SEC, AiRWA confirmed the stake build by director Michael Anthony Belfiore, which the company disclosed earlier this month. A Schedule 13D is filed by a person who acquires more than 5% of a voting class of a company’s stock, and who does not otherwise qualify to file a short-form report on Schedule 13G. It has to be filed within 10 days of the purchase of more than 5% stake.&nbsp;The company filed a Form 4 with the SEC on Oct. 15, stating that Belfiore purchased 3.21 million AiWA stock shares between Oct. 8 and Oct. 10, valued at $1.03 million. According to the 13D filing, Belfiore now holds a 22.1% stake in AiRWA.AiRWA, formerly Connexa Sports Technologies, rebranded itself to the present name on Oct. 7, underlining its thrust into the Web3 space and blockchain technology. In late August, the company, which was then called Connex Sports, struck a $500 million agreement with Singapore-based JuCoin to establish aiRWA, a next-generation digital asset platform jointly.&nbsp;According to the companies, the venture will focus on real-world asset (RWA) tokenization aimed at bringing traditional investments such as real estate, government bonds, and fine arts into a digital format. As part of the deal, JuCoin committed a $100 million investment in AiRWA, including about $30 million of Solana (SOL) tokens.<h2 class="st-heading-2">How Retail Feels About AiRWA Stock</h2>On Stocktwits, retail sentiment toward AiRWA stock shifted to ‘extremely bullish’ from the ‘bullish’ mood seen a day ago. The message volume remained at ‘extremely high’ levels. Retail chatter spiked nearly 3,500% in the 24 hours leading up to late Tuesday.<figure class="image"><img style="aspect-ratio:621/57;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_22_at_1_55_49_AM_png_5452a973dc.webp" alt="Screenshot 2025-10-22 at 1.55.49 AM.png" width="621" height="57"><figcaption>YYAI sentiment and message volume as of 1:55 a.m. ET, Oct. 22 | source: Stocktwits</figcaption></figure>One bullish user said “FOMO” fear will kick in once the stock reaches $0.50, and predicted a move to $1. Another user noted that retail traders’ support could push the price past the level.<stembedurl>https://stocktwits.com/ineedmore/message/633174405</stembedurl><stembedurl>https://stocktwits.com/ineedmore/message/633172951</stembedurl>AirWA stock, which fell 19.18% on Tuesday to $0.0809, was seen jumping 44% in overnight trading, according to Yahoo Finance.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-pega-stock-surge-over-13-in-after-hours-trading/cLGPxWaR3pl">Why Did PEGA Stock Surge Over 13% In After-Hours Trading?</a>

YYAI Stock Rockets After Insider Buying Reveal: Retail Trader FOMO Builds

In an amended regulatory filing, AiRWA confirmed a stake built by director Michael Anthony Belfiore.

Shares of Achieve Life Sciences, Inc. (ACHV) soared 32% on Friday afternoon after the company said that the U.S. Food and Drug Administration (FDA) awarded the company a Commissioner's National Priority Voucher (CNPV) for its Cytisinicline.The voucher is only available to nine programs in the program’s inaugural year. The program, announced in June, aims to reduce FDA assessment times to one to two months from the standard 10 to 12 months.Achieve Life Sciences’ Cytisinicline is indicated for nicotine e-cigarette or vaping cessation. “It's been nearly two decades since a new treatment option for smoking cessation was approved, and there are currently no treatment options for vaping cessation,” Achieve CEO Rick Stewart <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/17/3168544/0/en/Achieve-Life-Sciences-Receives-FDA-Commissioner-s-National-Priority-Voucher-for-Cytisinicline-for-Treatment-of-Nicotine-Dependence-for-E-cigarette-or-Vaping-Cessation.html">said</a>.In a mid-stage trial, participants treated with Cytisinicline were found to be 2.6 times more likely to quit using nicotine e-cigarettes or vapes compared to placebo. The FDA has agreed on a late-stage trial design that, together with the mid-stage data, would support an application for approval in vaping cessation.In September, the FDA accepted the company’s application for Cytisinicline as a treatment for smoking cessation. The agency is expected to decide on the application by June 20, 2026.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ACHV">ACHV stock</a> jumped from ‘neutral’ to ‘extremely bullish’ territory while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:588/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_17_at_1_41_17_PM_png_6eea8f50e0.webp" alt="ACHV's Sentiment Meter and Message Volume as of 1:41 p.m. ET on Oct. 17, 2025 | Source: Stocktwits" width="588" height="62"><figcaption>ACHV's Sentiment Meter and Message Volume as of 1:41 p.m. ET on Oct. 17, 2025 | Source: Stocktwits</figcaption></figure>Other drugs awarded the voucher under the FDA program include Merck Group’s infertility treatment Pergoveris, Sanofi’s Type 1 diabetes therapy Teplizumab, Regeneron’s gene therapy DB-OTO for congenital deafness, and more.ACHV stock is up by 15% this year and down by about 20% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/kezar-life-sciences-stock-hit-with-downgrades-price-target-cuts/ch6sK5FR38U">Kezar Life Sciences Stock Hit With Downgrades And Price Target Cuts: Retail Keeps Hopes Alive</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration a 13 year old schoolboy holds single-use Vapes for Recycling in Kingston on Thames, England. (Photo by Peter Dazeley/Getty Images)

Achieve Life Sciences Stock Soars On Receiving FDA Voucher For Expediting Review Of Investigational Drug In Vaping Cessation

The program, announced in June, aims to reduce the time taken for FDA assessments from the standard 10 to 12 months to one to two months.

Kezar Life Sciences (KZR) shares rallied 47% on Friday afternoon despite analyst downgrades and price target cuts.Jefferies analyst Maury Raycroft downgraded Kezar Life Sciences to ‘Hold’ from ‘Buy’ with a price target of $7, down from $18. Meanwhile, William Blair analyst Matthew Phipps downgraded Kezar Life Sciences to ‘Market Perform’ from ‘Outperform’ without a price target. Wells Fargo kept its ‘Equal Weight’ rating on the shares but slashed the price target to $5 from $7.Kezar <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.kezarlifesciences.com/news-releases/news-release-details/kezar-life-sciences-announces-regulatory-update-zetomipzomib">announced</a> on Thursday that it has initiated a process to explore strategic alternatives focused on maximizing shareholder value after being unable to align with the U.S. Food and Drug Administration on a potential registrational clinical trial of Zetomipzomib in patients with relapsed and refractory autoimmune hepatitis (AIH). Autoimmune hepatitis is a rare, chronic disease that predominantly affects women and, if left untreated, can lead to cirrhosis, liver failure, and hepatocellular carcinoma.However, the FDA Division of Hepatology and Nutrition cancelled a Type C meeting that was previously scheduled with Kezar in the fourth quarter to discuss a proposed study in AIH, the company said.Earlier this year, Kezar reported positive safety and efficacy data from a clinical trial in patients with refractory or relapsed AIH. However, the regulator requested that Kezar conduct a stand-alone study to define the pharmacokinetics of Zetomipzomib in subjects with significant hepatic impairment before the initiation of another clinical trial in AIH.This study would delay future trials of Zetomipzomib in AIH by approximately two years, the company said, while adding that the requirements put forth by the FDA would also hinder patient enrollment and participation.“While we remain excited about the potential of Zetomipzomib to be the first approved agent in AIH, we lack the resources to extend the development timeline,” CEO Chris Kirk said.The company also said it would be implementing a restructuring plan, including layoffs and other cash conservation measures, as part of the strategic alternative evaluation.William Blair said on Friday that it is surprised to see the FDA refusing to host a Type C meeting. Considering Kezar's current cash balance and liabilities, Blair believes a potential acquisition in the $6 to $7 per share range could be feasible.Wells, however, thinks there could be upside if they return cash to shareholders or in a reverse merger scenario.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/KZR">KZR stock</a> soared from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:589/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_17_at_12_46_33_PM_png_393ca210c9.webp" alt="KZR's Sentiment Meter and Message Volume as of 12:46 p.m. ET on Oct. 17, 2025 | Source: Stocktwits" width="589" height="62"><figcaption>KZR's Sentiment Meter and Message Volume as of 12:46 p.m. ET on Oct. 17, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that $6.50 to $7 would be a good range for the stock.<stembedurl>https://stocktwits.com/StockBoyAri/message/632736011</stembedurl>Another user expressed doubts over the rally.<stembedurl>https://stocktwits.com/CMCanalyst/message/632743196</stembedurl>KZR stock is down by 9% this year and by about 25% over the past 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/artiva-biotherapeutics-gets-price-target-hike-from-wedbush/ch6sW9tR38A">Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Kezar Life Sciences Stock Hit With Downgrades And Price Target Cuts: Retail Keeps Hopes Alive

Kezar announced on Thursday that it was unable to align with the FDA on a potential registrational clinical trial of Zetomipzomib in patients with relapsed and refractory autoimmune hepatitis.

Veritone (VERI) stock became the third-most trending ticker on Stocktwits, and its shares fell nearly 17% in early trading after the company announced an equity offering of approximately 12.87 million shares of common stock&nbsp;at a purchase price of $5.83 per share.Notably, despite the slide, the stock was still trading at $6.98 at the time of writing.&nbsp;The aggregate gross proceeds from the offering are expected to be about $75 million, before deducting offering expenses payable by the company.&nbsp;Veritone said that it intends to use the net proceeds from the offering, together with its existing cash and cash equivalents, for working capital and general corporate purposes. The company said this could also include capital expenditures, debt service, and repayment of indebtedness.Retail sentiment on Veritone remained unchanged in the ‘extremely bullish’ territory compared to a day ago, with message volumes at ‘extremely high’ levels, according to data from Stocktwits.On Tuesday, the company announced that it has secured major contract wins to deploy its Veritone Data Refinery (VDR) product offering. The firm also reported preliminary third-quarter results and said it expects revenue of $28.5 million to $28.7 million, compared with the prior forecast of $28 million to $30 million.Veritone also said it is now estimating an adjusted loss of $5.5 million to $6 million, compared to its initial expectation of an adjusted loss of $6.5 million to $6 million.<a href="https://stocktwits.com/symbol/VERI">Shares of Veritone</a> have gained over 121% this year and have jumped 74.5% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/above-food-stock-becomes-top-trending-ticker-on-stocktwits/ch6pPOfR3nm">Above Food Stock Becomes Top Trending Ticker On Stocktwits, Draws Massive Retail Interest After Breaking Out Above $5-Mark In October</a>

Why Did Veritone Stock Fall 17% Today?

Veritone said the purchase price is $5.83 per share in a registered direct offering, and the aggregate gross proceeds from the offering are expected to be about $75 million, before deducting offering expenses payable by the company. 

Shares of autonomous-vehicle (AV) technology company Cyngn, Inc. (CYN)&nbsp;rose over 0.50% in early premarket trading on Wednesday, suggesting they could witness follow-on buying after two consecutive sessions of gains.The strong rally in<a href="https://stocktwits.com/symbol/CYN">&nbsp;Cyngn stock</a> on Tuesday came after the company announced a<a href="https://stocktwits.com/news-articles/markets/equity/why-is-cyngn-stock-surging-22-percent-pre-market-today/ch6mo2wR3mL">&nbsp;commercial DriveMod Tugger deployment</a> with PepsiCo's (PEP) largest independent bottler in the U.S., G&amp;J Pepsi.&nbsp; DriveMod is Cyngn's autonomous vehicle technology that transforms industrial vehicles, such as forklifts and tuggers, into self-driving robots.Following the news, retail trader buzz&nbsp;surged, overwhelming the Cyngn stream on Stocktwits with messages. The message volume change on the Cyngn stream spiked 11,500% over the 24 hours leading up to late Tuesday. On Stocktwits, retail sentiment improved to 'extremely bullish' (87/100) as of early Wednesday, from 'bullish' the day before.<figure class="image"><img style="aspect-ratio:621/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_15_at_4_36_40_AM_png_0bbfe8acb5.webp" alt="Screenshot 2025-10-15 at 4.36.40 AM.png" width="621" height="53"><figcaption>CYN sentiment and message volume as of 4:35 a.m. ET, Oct. 15 | source: Stocktwits</figcaption></figure>A bullish user noted that the partnerships with Pepsi and Nvidia will provide Cyngn with cash for the next two years. In June, the company said its autonomous industrial vehicles, built on Nvidia&nbsp; Isaac and powered by DriveMod software, were currently operating in commercial environments to reduce labor costs, increase throughput, and improve safety.<stembedurl>https://stocktwits.com/kitir92/message/632357308</stembedurl>Another user expected the stock to trade above $10 on Wednesday.<stembedurl>https://stocktwits.com/time4themoon/message/632349740</stembedurl>Cyngn stock is down about 96% year-to-date, grossly underperforming the broader market. According to Koyfin, the average price target for the stock is $12, suggesting roughly 110% upside from current levels. Cyngn stock has traded in a 52-week range of $3.62-$1,312.50.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp; <a href="https://stocktwits.com/news-articles/markets/equity/asml-stock-rises-premarket-after-q3-results/ch6nYiSR3Zy">ASML Stock Rises Premarket After Q3 Results: Margin Outlook Raised On AI Chip Boom</a>

 In this photo illustration, the Cyngn logo is seen displayed on a smartphone screen.

Cyngn Stock Eyes Third Day Of Gains: What's Driving The Buzz?

Cyngn stock is down about 96% year-to-date, grossly underperforming the broader market.

Current Price	$150.23
Prev Close	$146.81
Open	$150.16
Dividend Yield	N/A
50-Day Moving Average	$151.79
Beta	N/A
Avg. Volume	43,010.87
PE Ratio	N/A

52-Week High	$161.95
52-Week Low	$95.25
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

IWC
iShares Micro-Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IWC News

IWCiShares Micro-Cap ETF